Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival (Q34552759)

3 August 2017

title

Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival (English)

1 reference

3 August 2017

1 reference

Bar-Sela G

1 reference

3 August 2017

Kaplan-Cohen V

1 reference

3 August 2017

Ilan N

1 reference

3 August 2017

Vlodavsky I

1 reference

3 August 2017

Ben-Izhak O

1 reference

3 August 2017

publication date

1 August 2006

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

188-193

1 reference

Heparanase: a key enzyme involved in cell invasion

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase, a potential regulator of cell-matrix interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparin-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Functions of cell surface heparan sulfate proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Processing and activation of latent heparanase occurs in lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase expression during normal liver development and following partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Human heparanase is localized within lysosomes in a stable form

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

State-of-the-art management of nasopharyngeal carcinoma: current and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02469.X

10.1111/J.1365-2559.2006.02469.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference